Skip to main content

New Products: Quanterix Launches Simoa Instrument and More

Premium

Quanterix this week launched a commercial, research-use-only version of its Single Molecule Array, Simoa, platform.

According to the company, the platform can measure proteins at concentrations 1,000 times lower than the best current immunoassays. Additionally, it offers four logs of dynamic range, multiplexing of up to ten analytes, and throughput of 80 samples per hour.


ProteinSimple has released its FluorChem R system, a fully integrated, multimode gel and Western blot imager with chemiluminescent, fluorescent, and infrared detection capabilities.

The system comes with an 8.3 megapixel CCD camera, touch-screen interface, on-board computer, and Digital Darkroom acquisition and analysis software.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.